Showing 61 - 80 results of 167 for search '"Esophageal cancer"', query time: 0.06s Refine Results
  1. 61

    IgG4-mediated M2 macrophage polarization in tertiary lymphoid structures of esophageal cancer: implications for immunosuppression by Hui Wang, Hui Wang, Jirui Li, Yinghai Wang, Yang Chen, Yang Chen, Weifeng Zhang, Xinyan Pan, Xinyan Pan, Chanjuan Su, Ziteng Li, Li Wang, Li Wang, Jiang Gu, Jiang Gu

    Published 2025-01-01
    “…This study aims to analyze the distribution characteristics of IgG4-expressing cells, regulatory T cells (Tregs), and M2-type macrophages as well as to elucidate the relationship between IgG4 and the polarization of M2 macrophages within TLS in esophageal cancer.ObjectTo elucidate the distribution of IgG4, Treg cells, and M2 macrophages in TLS and to assess the impact of IgG4 on macrophage polarization.MethodsEsophageal cancer tissue were analyzed with multiplex immunofluorescence to determine the spatial distribution and density of B cells, T cells, and their subtypes. …”
    Get full text
    Article
  2. 62
  3. 63
  4. 64

    Genetic Polymorphisms in the RAD51 Gene with a Risk of Head and Neck Cancer and Esophageal Cancer: A Meta-Analysis by Lin Li, Xue Zhang, Zhong-Ti Zhang

    Published 2019-01-01
    “…The role of RAD51 gene polymorphisms with the development of head and neck cancer (HNC) and esophageal cancer (EC) remains controversial. This meta-analysis was conducted to evaluate the correlation between the RAD51 polymorphisms and these two cancers quantitatively. …”
    Get full text
    Article
  5. 65
  6. 66
  7. 67
  8. 68
  9. 69
  10. 70
  11. 71
  12. 72
  13. 73
  14. 74
  15. 75
  16. 76
  17. 77
  18. 78

    A re-look at the modified Ryan regression scoring system in esophageal cancer—validation of prognostic significance and comparison with other less commonly used systems by Paromita Roy, Rupanita Biswal, Sayali N. Honap, Robin Thambudorai, Tapesh Bhattacharyya, Indranil Mallick

    Published 2024-12-01
    “…Background: Neoadjuvant chemoradiotherapy (NACRT) using CROSS protocol is currently the treatment of choice for esophageal cancer (EC). Tumor response grade (TRG) is a mandatory reporting criterion in most guidelines. …”
    Get full text
    Article
  19. 79
  20. 80